Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2002 2
2003 3
2004 3
2005 3
2006 2
2019 1
2021 1
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.
Lunati ME, Cimino V, Gandolfi A, Trevisan M, Montefusco L, Pastore I, Pace C, Betella N, Favacchio G, Bulgheroni M, Bucciarelli L, Massari G, Mascardi C, Girelli A, Morpurgo PS, Folli F, Luzi L, Mirani M, Pintaudi B, Bertuzzi F, Berra C, Fiorina P. Lunati ME, et al. Among authors: morpurgo ps. Pharmacol Res. 2022 Sep;183:106396. doi: 10.1016/j.phrs.2022.106396. Epub 2022 Aug 12. Pharmacol Res. 2022. PMID: 35970329
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide.
Lunati ME, Cimino V, Bernasconi D, Gandolfi A, Morpurgo PS, Tinari C, Lazzaroni E, Baruffaldi L, Muratori M, Montefusco L, Pastore I, Rossi A, Franzetti IG, Muratori F, Manfrini R, Disoteo OE, Terranova R, Desenzani P, Girelli A, Ghelardi R, D'Addio F, Ben Nasr M, Berra C, Folli F, Bucciarelli L, Fiorina P. Lunati ME, et al. Among authors: morpurgo ps. Pharmacol Res. 2024 Jan;199:107040. doi: 10.1016/j.phrs.2023.107040. Epub 2023 Dec 20. Pharmacol Res. 2024. PMID: 38128857 Free article.
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy.
D'Addio F, Pastore I, Loretelli C, Valderrama-Vasquez A, Usuelli V, Assi E, Mameli C, Macedoni M, Maestroni A, Rossi A, Lunati ME, Morpurgo PS, Gandolfi A, Montefusco L, Bolla AM, Ben Nasr M, Di Maggio S, Melzi L, Staurenghi G, Secchi A, Bianchi Marzoli S, Zuccotti G, Fiorina P. D'Addio F, et al. Among authors: morpurgo ps. Acta Diabetol. 2022 Sep;59(9):1157-1167. doi: 10.1007/s00592-022-01911-1. Epub 2022 Jun 22. Acta Diabetol. 2022. PMID: 35729357 Free PMC article.
Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes.
D'Addio F, Sabiu G, Usuelli V, Assi E, Abdelsalam A, Maestroni A, Seelam AJ, Ben Nasr M, Loretelli C, Mileto D, Rossi G, Pastore I, Montefusco L, Morpurgo PS, Plebani L, Rossi A, Chebat E, Bolla AM, Lunati ME, Mameli C, Macedoni M, Antinori S, Rusconi S, Gallieni M, Berra C, Folli F, Galli M, Gismondo MR, Zuccotti G, Fiorina P. D'Addio F, et al. Among authors: morpurgo ps. Diabetes. 2022 Aug 1;71(8):1800-1806. doi: 10.2337/db22-0053. Diabetes. 2022. PMID: 35551366 Free article.
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study.
Lazzaroni E, Lunati ME, Montefusco L, Pastore I, Chebat E, Cimino V, Morpurgo PS, Muratori M, Plebani L, Bolla A, Rossi A, Vallone L, Gandolfi A, Tinari C, D'Addio F, Nasr MB, Loretelli C, Scaranna C, Bellante R, Manfrini R, Muratori F, Franzetti I, Orsi E, Gazzaruso C, Ghelardi R, Desenzani P, Genovese S, Girelli A, Folli F, Berra C, Fiorina P. Lazzaroni E, et al. Among authors: morpurgo ps. Pharmacol Res. 2022 Sep;183:106374. doi: 10.1016/j.phrs.2022.106374. Epub 2022 Jul 28. Pharmacol Res. 2022. PMID: 35908663
Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS, Cappiello V, Verga U, Vicentini L, Vaghi I, Lauri E, Nebuloni M, Beck-Peccoz P, Spada A. Morpurgo PS, et al. Clin Endocrinol (Oxf). 2005 Oct;63(4):437-41. doi: 10.1111/j.1365-2265.2005.02360.x. Clin Endocrinol (Oxf). 2005. PMID: 16181236
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group.
Ferretti F, Cannatelli R, Benucci M, Carmagnola S, Clementi E, Danelli P, Dilillo D, Fiorina P, Galli M, Gallieni M, Genovese G, Giorgi V, Invernizzi A, Maconi G, Maier JA, Marzano AV, Morpurgo PS, Nebuloni M, Radovanovic D, Riva A, Rizzardini G, Sabiu G, Santus P, Staurenghi G, Zuccotti G, Sarzi-Puttini PC, Ardizzone S. Ferretti F, et al. Among authors: morpurgo ps. Front Immunol. 2021 Apr 15;12:656362. doi: 10.3389/fimmu.2021.656362. eCollection 2021. Front Immunol. 2021. PMID: 33936084 Free PMC article.
Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.
Lunati ME, Morpurgo PS, Rossi A, Gandolfi A, Cogliati I, Bolla AM, Plebani L, Vallone L, Montefusco L, Pastore I, Cimino V, Argenti S, Volpi G, Zuccotti GV, Fiorina P. Lunati ME, et al. Among authors: morpurgo ps. Front Endocrinol (Lausanne). 2022 Apr 14;13:816599. doi: 10.3389/fendo.2022.816599. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35498423 Free PMC article.
Circulating levels of ghrelin in human fetuses.
Cortelazzi D, Cappiello V, Morpurgo PS, Ronzoni S, Nobile De Santis MS, Cetin I, Beck-Peccoz P, Spada A. Cortelazzi D, et al. Among authors: morpurgo ps. Eur J Endocrinol. 2003 Aug;149(2):111-6. doi: 10.1530/eje.0.1490111. Eur J Endocrinol. 2003. PMID: 12887287
Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studies.
Fadini GP, Bonora BM, Lapolla A, Fattor B, Morpurgo PS, Simioni N, Avogaro A; DARWIN-T2D Network. Fadini GP, et al. Among authors: morpurgo ps. Diabetes Obes Metab. 2019 May;21(5):1255-1260. doi: 10.1111/dom.13623. Epub 2019 Jan 22. Diabetes Obes Metab. 2019. PMID: 30578607 Free PMC article.
25 results